A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
Clinical trial NCT06731907 · RECRUITING
Trial details
- NCT number
- NCT06731907
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-30
- Primary completion
- 2032-03-12
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.